Grassi Investment Management Novartis Ag Transaction History

Grassi Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 12, 2021	SELL	$83.5 - $98.47 $6.68 Million - $7.87 Million	-79,946 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$78.07 - $94.43 $698,726 - $845,148	-8,950 Reduced 10.07%	79,946 $7.55 Million
Q3 2020 Oct 13, 2020	BUY	$82.14 - $91.0 $26,695 - $29,575	325 Added 0.37%	88,896 $7.73 Million
Q2 2020 Jul 15, 2020	BUY	$80.93 - $91.1 $123,418 - $138,927	1,525 Added 1.75%	88,571 $7.74 Million
Q1 2020 Apr 08, 2020	BUY	$70.67 - $99.01 $543,452 - $761,386	7,690 Added 9.69%	87,046 $7.18 Million
Q4 2019 Jan 10, 2020	BUY	$84.35 - $95.37 $246,723 - $278,957	2,925 Added 3.83%	79,356 $7.51 Million
Q3 2019 Oct 04, 2019	BUY	$85.54 - $94.26 $381,508 - $420,399	4,460 Added 6.2%	76,431 $6.64 Million
Q2 2019 Jul 10, 2019	BUY	$75.4 - $92.8 $5.11 Million - $6.28 Million	67,725 Added 1595.03%	71,971 $6.57 Million
Q1 2019 Apr 10, 2019	BUY	$75.32 - $86.15 $319,808 - $365,792	4,246 New	4,246 $408,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

Stay updated on Grassi Investment Management with notifications on news.